Through in vitro and in vivo experiments using various xenograft models, BAFF CAR T-cells specifically targeted the three BAFF receptors (BAFF-R, BCMA, and TACI) and effectively eliminated several B cell malignancies, including MM [87]. This evidence concerns the gene TNFRSF13C and Miyoshi myopathy.